K. Michael Conaway bought Alexion Pharmaceuticals, Inc. (ALXN) (ALXN)
K. Michael Conaway (R-TX), a U.S. Representative, has disclosed 1 trade in Alexion Pharmaceuticals, Inc. (ALXN) (ALXN) since 2015, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: K. Michael Conaway bought $1,001 - $15,000 of Alexion Pharmaceuticals, Inc. (ALXN) (ALXN) on February 9, 2015. Since that trade, ALXN is up +0.00% against the S&P 500 up +337.68%, an outperformance of -337.68%.
Data updated
K. Michael Conaway's ALXN trades vs the price
ALXN is up +0.00% since K. Michael Conaway bought on February 9, 2015, versus +337.68% for the S&P 500.
Performance since this trade
All K. Michael Conaway ALXN trades
K. Michael Conaway & ALXN trading FAQ
Is it legal for K. Michael Conaway to trade Alexion Pharmaceuticals, Inc. (ALXN) (ALXN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Alexion Pharmaceuticals, Inc. (ALXN) (ALXN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did K. Michael Conaway buy ALXN?
K. Michael Conaway disclosed a purchase of $1,001 - $15,000 of Alexion Pharmaceuticals, Inc. (ALXN) (ALXN) on February 9, 2015, according to public STOCK Act filings.
How has ALXN performed since K. Michael Conaway's trade?
Since K. Michael Conaway bought ALXN on February 9, 2015, the stock is up +0.00%, versus +337.68% for the S&P 500 over the same period, an outperformance of -337.68%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ALXN trades?
Quantellect tracks every disclosed congressional trade in Alexion Pharmaceuticals, Inc. (ALXN) (ALXN) on the Alexion Pharmaceuticals, Inc. (ALXN) congressional trading page, which aggregates filings across all members of Congress.
K. Michael Conaway's ALXN tradesAll congressional filings for Alexion Pharmaceuticals, Inc. (ALXN)K. Michael Conaway's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.